← Back to all earnings calls

Immucell Corp /De/ Q4 FY2019 Earnings Call

Immucell Corp /De/ (ICCC)

Earnings Call FY2019 Q4 Call date: 2020-02-18 Concluded

Share

Quarter scorecard

Revenue (derived Q4)

$3.63M

+23.7% YoY

Gross margin (derived Q4)

50.6%

+3.1 pp YoY

Net income (derived Q4)

-$310,451

Documents & deck